Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biodyn Share News (OBD)

Share Price Information for Oxford Biodyn (OBD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.00
Bid: 8.00
Ask: 8.48
Change: -0.10 (-1.23%)
Spread: 0.48 (6.00%)
Open: 8.20
High: 8.20
Low: 8.00
Prev. Close: 8.10
OBD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS: Hyve chair and CEO buy as share price hit by Russia

Thu, 03rd Mar 2022 15:26

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and not separately reported by Alliance News:

----------

Hyve Group PLC - London-based events organiser - Chair Richard Last and Chief Executive Officer Mark Shashoua buy 100,000 shares each at 60.00p and 60.17p, worth GBP120,167, on Thursday. Hyve on Monday said it had postponed events scheduled to be held in Ukraine until further notice, though these represent only 3% of company revenue. There has been no impact yet on its events schedule in Russia, but it expects disruption to Western participation. Is assessing potential financial impact of sanctions by EU, UK and US against Russia. The YugAgro agricultural trade show in Russia is one of Hyve's top 10 events. The stock is down 45% in the past month.

----------

Melrose Industries PLC - London-based industrial turnaround specialist - Four non-executive directors, led by Chair Justin Dowley, buy a total of 167,000 shares at 132.26p to 136.51p, worth about GBP220,000, on Thursday. Dowley bought 75,000 of the shares. Melrose on Thursday reported 2021 results, saying it had narrowed its loss but faced headwinds from semiconductor shortages and Covid disruption.

----------

Oxford BioDynamics PLC - biotechnology firm focused on discovery and development of epigenetic biomarkers - Non-Executive Director Stephen Diggle buys 543,997 shares via Vulpes Testudo Fund at 22.3 pence, worth GBP121,311, on Tuesday and Wednesday. Diggle now is interested in 15.7 million shares, a 15.6% stake.

----------

Uniphar PLC - Dublin-based healthcare services - Non-Executive Director Paul Hogan buys 42,098 shares at EUR3.40, worth EUR143,133, on Wednesday.

----------

Tyman PLC - London-based door and window components supplier - Non-Executive Director Paul Withers purchases 20,000 shares a GBP3.55 each, worth GBP71,000, on Thursday.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
21 May 2019 16:05

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 22 May Marks & Spencer GroupFull Year ResultsRoyal MailFull Year Year Year

Read more
3 May 2019 14:19

Oxford BioDynamics Chosen To Join ALS Biomarker Study

LONDON (Alliance News) - Oxford Biodynamics PLC said on Friday it has joined the REFINE-ALS study, designed to identify specific biomarkers in people with amyotrophic lateral sclerosis.The

Read more
23 Apr 2019 10:33

Three AIM firms celebrate Queen's Award for Enterprise wins

(Sharecast News) - Three firms trading on London's AIM market were celebrating wins in the Queen's Award for Enterprise on Tuesday, with Inspiration Healthcare, Ergomed and Oxford BioDynamics all picking up the accolades.

Read more
5 Apr 2019 11:25

Oxford BioDynamics Appoints Non-Executive Director As Interim Chair

LONDON (Alliance News) - Oxford BioDynamics PLC said on Friday it has promoted Non-Executive Director Steven Wiggle as interim chair with immediate effect.Wiggle will be replacing David who

Read more
2 Apr 2019 12:08

Oxford BioDynamics Launches US Business With New Commerical Head

LONDON (Alliance News) - Biotechnology firm Oxford BioDynamics PLC said Tuesday it has established a US subsidiary and appointed a commercial head for the country.In line with its strategy

Read more
19 Mar 2019 11:54

Oxford BioDynamics EpiSwitch Test Included In Cancer Screening Study

LONDON (Alliance News) - Oxford BioDynamics PLC on Tuesday said it has signed an agreement for its EpiSwitch test to be used by Imperial College London in a prostate cancer screening College is to

Read more
19 Mar 2019 11:43

Oxford BioDynamics biomarker to be used in prostate cancer test trial

(Sharecast News) - Oxford BioDynamics announced on Tuesday that it has signed an agreement with Imperial College London, to utilise its latest 'EpiSwitch' biomarker signature for the blood-based diagnosis of prostate cancer in the 'PROSTAGRAM' trial.

Read more
15 Feb 2019 14:55

DIRECTOR DEALINGS: Oxford BioDynamics Non-Exec's Associate Buys Shares

LONDON (Alliance News) - Oxford BioDynamics PLC on Friday said that the Vulpie Life Sciences Fund, controlled by Non-Executive Director Steven Diggle, purchased nearly GBP37,000 in stock over two

Read more
11 Jan 2019 10:21

Oxford Biodynamics Chair And Long-Serving Non-Exec To Stand Down

LONDON (Alliance News) - Biotechnology company Oxford Biodynamics PLC said Friday Chair David Williams and Non-Executive Director Alison Kibble will stand down later in 2019.Williams - 2016

Read more
11 Dec 2018 11:47

Oxford BioDynamics Annual Loss Narrows On Lower Costs

LONDON (Alliance News) - Oxford BioDynamics PLC on Tuesday reported a sharply narrowed annual loss due to absence of initial public offering related costs.For the year ended September 30, a

Read more
29 Aug 2018 17:03

GL Healthcare Holds 5% Oxford Biodynamics Stake After Deal (ALLISS)

LONDON (Alliance News) - Oxford Biodynamics PLC said Wednesday that GL Healthcare Investment LP holds a 5.1% stake in the biotechnology company after a transaction on Tuesday.GL holding the

Read more
22 Aug 2018 10:26

Chinese Investor Chooses Oxford BioDynamics As First European Partner (ALLISS)

LONDON (Alliance News) - Oxford BioDynamics PLC on Wednesday said a Chinese investment management firm has invested GBP9.8 million in the company.GL Capital Group, which focuses on firms, a

Read more
22 Aug 2018 08:39

Oxford BioDynamics sets sights on China following GL investment

(Sharecast News) - AIM-listed biotechnology company Oxford BioDynamics has launched a strategic partnership with GL Capital, a Chinese healthcare-focused investment group.

Read more
22 May 2018 14:06

Oxford BioDynamics Interim Loss Narrows On Increased Revenue

LONDON (Alliance News) - Oxford BioDynamics PLC on Tuesday reported a narrowed first half loss on the back of increase in revenue.The epigenetic biomarker developer recorded a pretax loss a

Read more
15 May 2018 16:10

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 16 May C&C GroupFull Year ResultsBurberry GroupFull Year & Year Year 17

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.